Electrical Geodesics, Inc. Expands Clinical Product Line Through Distribution Agreement With EB Neuro

EUGENE, OREGON, US, 22 April 2015 – Electrical Geodesics, Inc. (“EGI” or the “Company”), a leading neurodiagnostic medical technology company, today announces it has entered into an agreement to distribute a range of EEG products manufactured by EB Neuro S.p.A. (“EB Neuro”) in the US market. Sold under the EGI name, the products will expand the Company’s US product line to include long term monitoring and ambulatory EEG, and electromyography/evoked potential (“EMG/EP”) products, providing a broader portfolio of related neurology monitoring products for the clinical market.

EB Neuro, based in Northern Italy, develops, markets and distributes a wide range of medical devices. This agreement supplements existing collaborations between the two companies, with EB Neuro manufacturing the GEM low channel count ambulatory EEG device sold by EGI and serving as EGI’s distributor in Italy.

EB Neuro’s NeMus, NeMus 2, BE Micro and BE Plus LTM products are well established and sold worldwide and are CE marked and 510(k) cleared. They offer a practical and cost-effective solution for routine clinical and research use. The devices operate with EB Neuro’s proprietary Galileo operating software, a Windows-based system that has recently been cleared for sale for clinical use in the US.

Don Tucker, CEO of EGI, commented: “Having worked with EB Neuro for many years, we admire the innovation they deliver and their manufacturing capabilities. Their devices and software are a perfect adjunct and complement to our GES 400 devices. Whilst our GES 400 high-density EEG systems target the more advanced clinical uses and translational research in clinics and hospitals, the EB Neuro products expand our offering for the more routine needs of clinical customers.”

Ing. Marco Rossi, Managing Director of EB Neuro, commented: “Our Galileo software platform has recently received FDA 510(k) clearance and is a multidisciplinary platform which allows the use of all EB Neuro’s systems for neurological applications including EEG, EMG, EP and others. With its HL7 Protocol compatibility, Galileo is a highly compelling solution for hospital network integrations both in small clinics and in large hospital departments. EGI has a strong reputation and presence and we believe this alliance will deliver great benefits to both businesses in the important US clinical market.”

For more information contact:

EGI UK: Christine Soden, CFO
+44 (0) 7710 484199

Peel Hunt LLP (NOMAD and Broker)
+44 (0) 20 7418 8900
James Steel, Clare Terlouw

FTI Consulting (PR Advisors)
+44 (0) 20 3727 1000
Simon Conway, Mo Noonan

Notes to Editors

Electrical Geodesics, Inc. in Summary

Founded in 1992, EGI designs, develops and commercialises a range of non-invasive neurodiagnostic and neuromodulation products used to monitor, interpret and modulate brain activity, based on its proprietary dense array electroencephalography ("dEEG") platform technology. The Company’s technology uses up to 256 sensors, providing much higher resolution brain activity data compared to conventional 8 or 16 channel EEG and is used in medical, clinical and research settings in a diverse range of applications including important areas such as the diagnosis and monitoring of epilepsy, neurosurgical planning, sleep assessment, and many others.

Help employers find you! Check out all the jobs and post your resume.

Back to news